Minerva Neurosciences (NERV) Amortizatization of Intangibles (2014 - 2026)

Minerva Neurosciences (NERV) posted Amortizatization of Intangibles of $136741.0 for Q1 2026, up 3112.14% on a QoQ basis from $4257.0 in Q3 2024.

Minerva Neurosciences (NERV) Amortizatization of Intangibles (2014 - 2026) Analysis & Trends

Minerva Neurosciences' Amortizatization of Intangibles history runs 12 years deep, the most recent figure standing at $136741.0 for Q1 2026.

  • Quarterly Amortizatization of Intangibles changed N/A year-over-year to $136741.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136741.0 (up 1184.92% YoY) and the FY2024 annual result came in at $17027.0, down 33.33% from the prior year.
  • Amortizatization of Intangibles was $136741.0 for Q1 2026 at Minerva Neurosciences, up from $4257.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $136741.0 in Q1 2026 and bottomed at $4257.0 in Q3 2024.
  • A 4-year average of $20632.6 and a median of $6385.0 in 2022 frame the typical range for Amortizatization of Intangibles.
  • Annual changes were most pronounced in 2023 — Amortizatization of Intangibles changed 0.0% — and 2024, when it tumbled 33.33%.
  • Minerva Neurosciences' Amortizatization of Intangibles stood at $6385.0 in 2022, then changed by 0.0% to $6385.0 in 2023, then tumbled by 33.33% to $4257.0 in 2024, then jumped by 3112.14% to $136741.0 in 2026.
  • Business Quant data shows NERV's Amortizatization of Intangibles at $136741.0 in Q1 2026, $4257.0 in Q3 2024, and $6385.0 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Minerva Neurosciences 185.26 Mn 185.26 Mn - 136,741.00

Historic Data

Download Data
DateValue
Mar 31, 2026 136,741.00
Mar 31, 2026 136,741.00
Sep 30, 2024 4,257.00
Sep 30, 2024 4,257.00
Jun 30, 2024 6,385.00
Jun 30, 2024 6,385.00
Mar 31, 2024 6,385.00
Mar 31, 2024 6,385.00
Dec 31, 2023 6,385.00
Dec 31, 2023 6,385.00
Sep 30, 2023 6,385.00
Sep 30, 2023 6,385.00
Jun 30, 2023 6,385.00
Jun 30, 2023 6,385.00
Mar 31, 2023 6,385.00
Mar 31, 2023 6,385.00
Dec 31, 2022 6,385.00
Dec 31, 2022 6,385.00
Sep 30, 2021 14,939.00
Sep 30, 2021 14,939.00